• 08:30
• 

• Registration & Refreshments

• 08:50
• 

• Chairperson’s opening remarks

Improving Pharma Supply Chain

• 09:00
• 

• Keynote Panel Discussion: Maintaining Integrity & Transparency in the global pharmaceutical supply chain

  • Evaluation of the system regularly to identify weak areas
  • Implementing a comprehensive set of preventive best practices across the enterprise and all external stakeholders
  • What are the supply chain vulnerabilities?
  • Performing brand protection audits
  • Technologies being deployed to protect consumers and the integrity of brands
  • Overcoming supply chain challenges and actionable steps to increase efficiency

  ---

  

  Jim Marshall Associate Director, Devens Supply Chain
  Bristol-Myers Squibb

  

  Emre Gollu Supply Chain AD and CMC CL, TR & MEA; Head of Established Brands Alliances, TR
  UCB

• 09:30
• 

• Industry 4.0 and strategic adoption of new technologies in pharma supply chain

  • The strategic adoption of new technologies in pharma supply chain
  • How will Industry 4.0 affect the pharma industry and its stakeholders
  • Challenges faced by the industry when adopting these new technologies
  • New trends in pharmaceutical manufacturing that will be enabled by Industry 4.0, including predictive analytics, digital twins, robotics and more

   

  For sponsorship opportunities please contact: [email protected] or call +44 (0) 207 096 0786

• 10:00
• 

• Topic TBD

  ---

  

  Heiko Trefzger Product Manager, Business Analyst, Innovation Representative
  Roche

• 10:20
• 

• Designing an optimal supply chain network - Determine the right structure for your supply chain

  • Holistic end-to-end supply chain assessment considering internal and external perspectives
  • Adapting to changes in demand patterns, business environment
  • Streamlining your supply chain

• 10:40
• 

• Morning Coffee/Tea & Discussion

• 11:00
• 

• BMS Forensic Center of Excellence – Analytical Strategy and Processes for Detection of Counterfeit Drug Products

  ---

  

  Scott Huffman Associate Director Global Quality, Analytical Science & Technology
  Bristol-Myers Squibb

Serialization and Track & Trace

• 11:20
• 

• Panel Discussion: Implementing Well-organized, Adaptable and Effective End to End system

  • Highlighting serialization is business critical and planning early
  • Serialization preparation, challenges and trade partner readiness
  • IT as a major enabler in serialization
  • Effective and efficient project management

  ---

  

  Ulrich Schild Sales Director bei 3Keys GmbH
  3Keys GmbH

  

  Collins Agoro Strategic Program Manager-Sub-Saharan Africa
  Roche

• 11:50
• 

• Simple Authentication Technologies

  • Implementation and detection processes
  • Authentication of labels and boxes with cryptoglyph
  • Authentication of molded items with Fingerprint

  ---

  

  Fred Jordan CEO
  AlpVision

• 12:20
• 

• Networking luncheon

• 13:00
• 

• The need of unified management and sharing of serialisation data to maintain product safety standards

• 13:30
• 

• Optimizing Traceability and Tracking to combat counterfeiting

  • How will the pharmaceutical industry be benefited from traceability?
  • Drivers for global traceability
  • A Long-term Cost-Effective Serialisation And Traceability Strategies
  • Benefits Beyond Serialization and Traceability Compliance

   

  For sponsorship opportunities please contact: [email protected] or call +44 (0) 207 096 0786

• 14:00
• 

• Global serialization standard-implementing well organized, adaptable and effective system

  • Different requirements and regulations across geographies, what challenges does manufacturers face and the steps to overcome it?
  • Highlighting serialization is business critical and planning early is the key to success
  • Serialization preparation, challenges and trade partner readiness

  ---

  

  Ayse Baker Vice President of Regulatory Affairs
  Almatica

Smart Packaging & Labelling

• 14:20
• 

• Is the QR Code the Death of the GS1 DataMatrix Code?

  • Role of 2D GS1 DataMatrix and EAN/UPC linear barcodes today
  • Why do we see the use of QR codes increasing as well in the healthcare sector?
  • Where will it all end?

  ---

  

  Stefan Artlich Director 'Track&Trace'
  Bayer

• 14:40
• 

• The rising demand for Anti-counterfeit packaging – An increase in the trade among developed and developing countries

  • Current trends in the packaging market and strategies adopted by key players
  • Tamper Evident features in Packaging
  • Ensuring the packages comply with the new regulations and standards
  • Support from contract service providers, suppliers and others
  • Strategies currently employed by companies and countries that are ahead in curbing counterfeit medicines
  • Contract Packaging Market Trends

   

  Speaker TBC, Advanced Material Development

• 15:00
• 

• ePI and considerations of its impact on the supply chain

  • What ePI is, the benefits and challenges
  • A quick snapshot of the global status
  • Key implementation considerations for the supply chain

  ---

  

  Ronnie Mundair Senior Director - Regional Labelling Head
  Pfizer

  

  Matt Hancock Senior Director, Regional Lead, Head of Artwork Quality and Innovation
  Pfizer

• 15:20
• 

• Afternoon Tea/Coffee

• 15:40
• 

• Sustainable packaging digitization and its opportunities for a sound anti-counterfeiting strategy

  • How to use the digital technology to improve your anti-counterfeiting strategy?
  • What make an AC Strategy sound?
  • Sustainability and digitization are not contradictory

  ---

  

  Patrik Merckell CEO, Disruptor and Founder
  accent.world sa

• 16:00
• 

• Increasing the efficiency by Integrating anti-counterfeiting technologies in Packaging and Labelling

  • Track & Trace Technologies segment will augment the pharmaceutical packaging market
  • Disruptive technologies and regulatory implications on Packaging
  • Smart Packaging
  • Possible of use of nanotechnology in packaging
  • Digital packaging- to seal loopholes and increase flexibility
  • Possible combination of technologies to enhance and reinforce the security

   

  For sponsorship opportunities please contact: [email protected] or call +44 (0) 207 096 0786

• 16:20
• 

• Sustainable Pharmaceutical Packaging

  ---

  

  Monica De Leon EMEA Senior Distribution Manager
  Bristol-Myers Squibb

• 16:40
• 

• Implementing On-Dose Authentication Technologies

  • Mass digitalization of medicines offers new levels of brand authentication, supply chain security and transparency
  • The use of taggants is becoming more common following the publication of the US FDA guidance on the use of physical-chemical identifiers (PCIDs) in solid oral dosage forms (SODFs)
  • Microtags or taggants are uniquely encoded materials that are virtually impossible to replicate, or reverse engineer. They can be used to on finished products, ingredients or materials used to make products, and on packaging

  ---

  

  Gary Pond Global Product Authentication Lead
  Colorcon

CMOs and Partnerships

• 17:00
• 

• Flexible Manufacturing Partnerships have been a key to the success of pharma

   

  Partnerships are more important than ever with new regulations and competing priorities that need to be met in order to keep up today's pace

• 17:20
• 

• Case Study from Bayer - How to optimise selection processes for your CMOs by ensuring the right capabilities and competencies are being selected

  ---

  

  Luiz Alberto Barberini External Manufacturing Organization - Consumer Health LatAm ; Community Board Chair at CSCMP
  Bayer

• 17:50
• 

• Creating a Lean and Efficient Partner Management Model that is aligned with your Program's Critical Success Factors

• 18:10
• 

• Chairperson’s Closing Remark

• 18:20
• 

• Networking Drinks Session

• 08:30
• 

• Registration & Refreshments

• 08:50
• 

• Chairperson’s opening remarks

Data, Innovation & Technology

• 09:00
• 

• Data-driven sustainable supply chain management in the pharmaceutical and biopharmaceutical industries

   

  How to use data-driven approaches for sustainable supply chain management, as well as an evaluation of sustainability metrics that can be used for evaluating performance. It also provides examples from real-life cases where these techniques have been successfully implemented

  ---

  

  Cameron Mckinnell Head of Technology, Pharma Supply Chain & Strategy
  GSK

• 09:30
• 

• Big Data to create a more proactive drug supply strategy by collecting, analysing, and sharing information on the pharmaceutical supply chain

• 10:00
• 

• AI combined with predictive analytics will enable a more intuitive approach to pharmaceutical management which is data driven.

   

  For sponsorship opportunities please contact: [email protected] or call +44 (0) 207 096 0786

• 10:20
• 

• Morning Tea/Coffee

• 10:40
• 

• Case Study - Blockchain opportunities in the pharma supply chain and for detecting falsified drugs

  • Enable quality control throughout the supply chain
  • Added security from cyber threats
  • Single use system for all stakeholders
  • Tracking the movement of drugs throughout the supply chain
  • Incorporating blockchain into its serialization and traceability

  ---

  

  Alexandru Popa Associate Director | Blockchain for Pharma Supply Chain
  MSD

• 11:10
• 

• Building a smarter Supply chain - Power of AI and Blockchain

  • Increase visibility across systems and data sources
  • Increased collaboration, gain efficiencies and reduce costs
  • Proactively predict and mitigate disruptions

  ---

  

  Himanshu Agrawal Director - Global Process Owner & Innovation Lead, Supply Chain Logistics
  GSK, Pharmaledger

• 11:40
• 

• Enhancing Pharma Supply Chain Effectiveness through Process Automation

   

  For sponsorship opportunities please contact: [email protected] or call +44 (0) 207 096 0786

• 12:10
• 

• Panel discussion: Anti-counterfeiting and supply chain security - A scalable and future-proof system to battle counterfeiting

  • How will the future technologies be used in the supply chain: IoT, Analytics, Blockchain, AI and others?
  • Product identification and traceability solutions which can adapt to market changes and comply with serialization regulations in different countries
  • Building an interconnectivity across the supply chain
  • Planning and executing a sustainable strategy for the cost-effective implementation and driving ROI

• 12:40
• 

• Networking luncheons

Anticounterfeiting & Brand Safety

• 13:20
• 

• Tracking the magnitude of the counterfeit problem: A global perspective

  • The common Anti-counterfeiting strategies in EU, US and the rest of the world to handle the counterfeit medicines
  • Identification of countries severely affected by the counterfeit medicines
  • The challenges of combating counterfeit medicines in most affected countries
  • The loopholes in various legislations encouraging gray market to thrive

  ---

  

  Mario César Rojas Security Director - Mexico
  Bayer

• 13:40
• 

• Advancement in IP enforcement in Europe and what’s next?

  • New EU initiatives to counter growing IPR infringement and counterfeits
  • Reducing Intellectual Property Crime through Effective Partnerships
  • Intellectual property rights (IPR) laid down by the World Intellectual Property Organization (WIPO)
  • Brexit: English Intellectual Property law implications

   

  For sponsorship opportunities please contact: [email protected] or call +44 (0) 207 096 0786

Pharmacists, Public and Online Market Place

• 14:00
• 

• A safe and secure supply chain – that has never been more important than today

  ---

  

  Claire Clarke Director Healthcare Engagement
  GS1 Global Office

• 14:30
• 

• Cyber-security and anti-counterfeit programs: Detecting counterfeit sales and managing data for success

  ---

  

  Phil Blunden Defence Assurance & Information Security
  UK Ministry of Defence

• 15:00
• 

• Sensitizing the public about the counterfeit Pharma products to curb the sale of Counterfeits

  • Educating the public on the harmful nature of counterfeit medicines and how to identify
    and avoid them
  • The use of social media as a tool to reach
  • Organizing workshops & seminars to showcase real case examples

• 15:30
• 

• Afternoon Coffee/Tea & Networking

• 15:50
• 

• Role of Pharmacist’s in preventing counterfeit drugs

  • Ensuring safety, efficacy, quality of the drug imported
  • Good pharmacy practice guidelines
  • Usage of sophisticated tools to avoid counterfeiting
  • Work with the pharmaceutical industry, distributors, and the regulatory bodies to close gaps in the supply chain

• 16:10
• 

• European medicines verification system for Fighting counterfeit medicines to ensure patient safety

  ---

  

  Monika Derecque-Pois Director General
  GIRP

• 16:40
• 

• Interactive Roundtable Discussion

   

  All attendees will have a great opportunity to discuss a selection of the most interesting topics
  addressed during the conference in small groups with their peers.

   

  Every table will nominate a head of the table, who will summarize the topic discussed, present
  the main puzzles and questions posed.

• 17:10
• 

• Chairperson’s closing remarks & End of Conference